drugset / Trial / NCT06901726

Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males

NCT06901726

Phase 1 Not yet recruiting 10 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedCrossoverOpen-labelTreatment

Summary

Pharmacokinetics and pharmacodynamics study of 2 formulations (human insulin enteric coated capsules 32mg vs. human insulin injection 5IU) Relative biopotency and bioavailability of human insulin enteric coated capsules 32mg vs. human insulin injection 5IU

Timeline

Start
2025-03-31
Primary completion
2025-04-24
Completion
2025-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 5 iu Oral
Subject Insulin Protein / enzyme biologic 32 mg Oral

Indications